GWAS |
- Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) ( 28090653)
- Brain morphology (min-P) ( 32665545)
- Brain morphology (MOSTest) ( 32665545)
- Butyrylcholinesterase levels ( 21862451)
- Cortical surface area (MOSTest) ( 32665545)
- Cortical thickness (MOSTest) ( 32665545)
- Diverticular disease ( 30177863)
- Subclinical atherosclerosis traits (other) ( 17903303)
- Subcortical volume (min-P) ( 32665545)
- Subcortical volume (MOSTest) ( 32665545)
- Trunk fat mass ( 28552196)
- Urinary albumin-to-creatinine ratio ( 31511532)
|
- Angiotensin-converting enzyme inhibitor intolerance ( 28030426)
- Copper levels ( 26025379)
- Daytime nap ( 33568662)
- Dental caries ( 23259602)
- Disease progression in age-related macular degeneration ( 29346644)
- Electrocardiogram morphology (amplitude at temporal datapoints) ( 32916098)
- General risk tolerance (MTAG) ( 30643258)
- Insulin-related traits (multivariate analysis) ( 32002517)
- LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes ( 28736931)
- Methadone dose in opioid dependence ( 28115739)
- Night sleep phenotypes ( 27126917)
- Proinsulin levels ( 21873549)
- Response to cognitive-behavioural therapy in anxiety disorder ( 26989097 31123309)
|